Induction of cyclooxygenase-2 in monocyte/macrophage by mucins secreted from colon cancer cells

被引:70
作者
Inaba, T
Sano, H
Kawahito, Y
Hla, T
Akita, K
Toda, M
Yamashina, I
Inoue, M
Nakada, H [1 ]
机构
[1] Kyoto Sangyo Univ, Fac Engn, Dept Biotechnol, Kita Ku, Kyoto 6038555, Japan
[2] Hyogo Med Univ, Div Rheumatol, Dept Internal Med, Nishinomiya, Hyogo 6638501, Japan
[3] Kyoto Prefectural Univ Med, Dept Internal Med 1, Kamigyo Ku, Kyoto 6028566, Japan
[4] Univ Connecticut, Sch Med, Dept Physiol, Farmington, CT 06030 USA
关键词
D O I
10.1073/pnas.0435410100
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Up-regulation of cyclooxygenase-2 (COX-2) and overproduction of prostaglandins have been implicated in the initiation and/or progression of colon cancer. However, it is uncertain in which cells and how COX-2 is induced initially in the tumor microenvironment. We found that a conditioned medium of the colon cancer cell line, LS 180, contained a factor to induce COX-2 in human peripheral blood mononuclear cells. This factor was purified biochemically and revealed to be mucins. A small amount of mucins (approximate to100 ng of protein per ml) could elevate prostaglandin E2 production by monocytes. The mucins induced COX-2 mRNA and protein levels of monocytes in a dose- and time-dependent manner, indicating a COX-2-mediated pathway. We also have examined immunohistochemically the localization of COX-2 protein and mucins in human colorectal cancer tissues. It is noteworthy that COX-2-expressing macrophages were located around the region in which mucins were detectable, suggesting that COX-2 also was induced by mucins in vivo. These results suggest that mucins produced by colon cancer cells play a critical role in the initial induction of COX-2 in the tumor microenvironment.
引用
收藏
页码:2736 / 2741
页数:6
相关论文
共 41 条
[1]  
BAECKSTROM D, 1991, J BIOL CHEM, V266, P21537
[2]  
Bamba H, 1999, INT J CANCER, V83, P470, DOI 10.1002/(SICI)1097-0215(19991112)83:4<470::AID-IJC6>3.3.CO
[3]  
2-6
[4]   Nonsteroidal antiinflammatory drugs, eicosanoids, and colorectal cancer prevention [J].
DuBois, RN ;
Giardiello, FM ;
Smalley, WE .
GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 1996, 25 (04) :773-+
[5]   EICOSANOIDS AND THE GASTROINTESTINAL-TRACT [J].
EBERHART, CE ;
DUBOIS, RN .
GASTROENTEROLOGY, 1995, 109 (01) :285-301
[6]   TREATMENT OF COLONIC AND RECTAL ADENOMAS WITH SULINDAC IN FAMILIAL ADENOMATOUS POLYPOSIS [J].
GIARDIELLO, FM ;
HAMILTON, SR ;
KRUSH, AJ ;
PIANTADOSI, S ;
HYLIND, LM ;
CELANO, P ;
BOOKER, SV ;
ROBINSON, CR ;
OFFERHAUS, GJA .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (18) :1313-1316
[7]   Aspirin, NSAIDs, and colon cancer prevention: Mechanisms? [J].
Gupta, RA ;
DuBois, RN .
GASTROENTEROLOGY, 1998, 114 (05) :1095-1098
[8]   RECOGNITION AND PLASMA-CLEARANCE OF ENDOTOXIN BY SCAVENGER RECEPTORS [J].
HAMPTON, RY ;
GOLENBOCK, DT ;
PENMAN, M ;
KRIEGER, M ;
RAETZ, CRH .
NATURE, 1991, 352 (6333) :342-344
[9]   Cyclooxygenase 2 is up-regulated and localized to macrophages in the intestine of Min mice [J].
Hull, MA ;
Booth, JK ;
Tisbury, A ;
Scott, N ;
Bonifer, C ;
Markham, AF ;
Coletta, PL .
BRITISH JOURNAL OF CANCER, 1999, 79 (9-10) :1399-1405
[10]   Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer [J].
Hwang, D ;
Scollard, D ;
Byrne, J ;
Levine, E .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (06) :455-460